Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06289790
Other study ID # 16/BW/2023'
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 26, 2024
Est. completion date November 7, 2024

Study information

Verified date February 2024
Source Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
Contact Antoni Okninski, MD
Phone 608310346
Email antoniokninski@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare analgesic efficacy of erector spinae plane (ESP) block vs intravenous lignocaine infusion in video- assisted thoracoscopy (VATS. The main goals are to compare post- operative pain scores and cumulative post- operative opioid doses in both groups


Description:

Number of patients: 60 patients enrolled for VATS procedure randomly and evenly assigned to one of the 2 groups. Randomization: An online tool (Sealed EnvelopeTM[12]) will be used to randomly and evenly assign patients to one of the two groups. Blocks of 4,6,8 will be used and since the blocks assignment will be random as well, the total number of patients can be slightly larger than 60. On the day of the procedure an envelope containing one block of numbers will be opened and numbers from that envelope will be drawn for consecutive patients until the block is finished. Intervention: under general anaesthesia, preoperative ultrasound(USG) guided ESP blockade at Th5, single shot of 30 ml 0,3 % bupivacaine (not exceeding the maximum dose of 2 mg/kg of bupivacaine) with adrenaline 5 µg/ml and dexamethasone 0,15 mg/kg intravenously, post-operative infusion of 0,9% NaCl for 6 hours, infusion rate set as if it were lignocaine 1,5 mg/kg/h vs pre-induction lignocaine bolus of 1,5 mg/kg i.v. and dexamethasone 0,15 mg/kg intravenously, intraoperative infusion of lignocaine 2 mg/kg i.v., post-operative infusion of lignocaine 1,5 mg/kg i.v. for 6 hours Patient and nursing staff will be blinded to the performed intervention. Primary end- points: 1) pain score (static and dynamic defined as cough effort) on numerical rating score (NRS) 1,3,6,12 hours after surgery (and on discharge from post- anaesthesia care unit [PACU]/after 24 hours- whichever comes sooner) 2) cumulative opioid dose after 12 hours (and on discharge from PACU/after 24 hours- whichever comes sooner) Secondary end- points: 1) incidence of adverse effects such as: severe hypotension (defined as a 20% drop of either mean arterial pressure (MAP), systolic blood pressure (SBP) or diastolic blood pressure (DBP) compared to baseline measured in the ward prior to surgery)[BP measured at 1,3,6,12 hour and on discharge from PACU or more frequently if needed), nausea and vomiting, priuritis, local anaesthetic systemic toxicity symptoms. 2) intra- operative cumulative opioid dose 3) time to discharge from hospital (max. observation time: 30 days)


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date November 7, 2024
Est. primary completion date November 7, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - Age >18 - VATS for tumor resection or partial lung resection in emphysema - Written, informed consent obtained 1 day prior to surgery Exclusion criteria: - Lack of consent for ESP blockade - History of allergy to local anaesthetics - Other contraindications to ESP blockade - American Society of Anesthesiologists(ASA) Physical Status Classification value 4 or higher - VATS for indications other than tumor resection or partial lung resection in emphysema - Insulin- dependent diabetes mellitus - More than 1 chest drain post-operatively - Conversion to thoracotomy - Chronic opioid use prior to surgery defined as opioid administration for at least 3 months during the last 12 months - History of alcohol abuse - Suspected technical difficulties with performing the ESP block (e.g. obesity) - Inadequate spread of the local anaesthetic during the ESP block - Cognitive impairment that might cause an inaccurate assessment of pain levels

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Erector Spinae Plane (ESP) block
Erector Spinae Plane (ESP) block for pain management in VATS procedure
Drug:
Lignocaine
Lignocaine bolus and infusion for pain management in VATS procedure

Locations

Country Name City State
Poland National Medical Institute of the Ministry of the Interior and Administration Warsaw Mazowieckie

Sponsors (1)

Lead Sponsor Collaborator
Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland

Country where clinical trial is conducted

Poland, 

References & Publications (12)

Cohen, Edmond. Cohen's Comprehensive Thoracic Anesthesia. Available from: Elsevier eBooks+, Elsevier - OHCE, 2021

De Cassai A, Bonvicini D, Correale C, Sandei L, Tulgar S, Tonetti T. Erector spinae plane block: a systematic qualitative review. Minerva Anestesiol. 2019 Mar;85(3):308-319. doi: 10.23736/S0375-9393.18.13341-4. Epub 2019 Jan 4. — View Citation

Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451. — View Citation

Gola W, Zajac M, Cugowski A. Adiuwanty w blokadach nerwów obwodowych - aktualny stan wiedzy. Anestezjologia Intensywna Terapia. 2020:325-332.

Hou YH, Shi WC, Cai S, Liu H, Zheng Z, Qi FW, Li C, Feng XM, Peng K, Ji FH. Effect of Intravenous Lidocaine on Serum Interleukin-17 After Video-Assisted Thoracic Surgery for Non-Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial. Drug Des Devel Ther. 2021 Aug 3;15:3379-3390. doi: 10.2147/DDDT.S316804. eCollection 2021. — View Citation

Liu ZJ, Zhang LY, Zheng XG, Shen L, Song KC, Yi J, Huang YG. [Effects of Continuous Intravenous Intraoperative Lidocaine Infusion on Opioids Consumption and Postoperative Recovery in Patients Undergoing Video-assisted Thoracoscopic Lobectomy]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018 Apr 28;40(2):163-169. doi: 10.3881/j.issn.1000-503X.2018.02.005. Chinese. — View Citation

Misiolek H, Zajaczkowska R, Daszkiewicz A, Woron J, Dobrogowski J, Wordliczek J, Owczuk R. Postoperative pain management - 2018 consensus statement of the Section of Regional Anaesthesia and Pain Therapy of the Polish Society of Anaesthesiology and Intensive Therapy, the Polish Society of Regional Anaesthesia and Pain Therapy, the Polish Association for the Study of Pain and the National Consultant in Anaesthesiology and Intensive Therapy. Anaesthesiol Intensive Ther. 2018;50(3):173-199. doi: 10.5603/AIT.2018.0026. — View Citation

Sealed Envelope Ltd. 2022. Create a blocked randomisation list. [Online] Available from: https://www.sealedenvelope.com/simple-randomiser/v1/lists

Slovack M, Taylor B, Bryce R, Ong D. Does intravenous lidocaine infusion during video-assisted thoracoscopic surgery reduce postoperative analgesia? A randomized controlled study. Can J Anaesth. 2015 Jun;62(6):676-7. doi: 10.1007/s12630-015-0333-z. Epub 2015 Feb 11. No abstract available. — View Citation

Umari M, Falini S, Segat M, Zuliani M, Crisman M, Comuzzi L, Pagos F, Lovadina S, Lucangelo U. Anesthesia and fast-track in video-assisted thoracic surgery (VATS): from evidence to practice. J Thorac Dis. 2018 Mar;10(Suppl 4):S542-S554. doi: 10.21037/jtd.2017.12.83. — View Citation

Wang L, Sun J, Zhang X, Wang G. The Effect of Lidocaine on Postoperative Quality of Recovery and Lung Protection of Patients Undergoing Thoracoscopic Radical Resection of Lung Cancer. Drug Des Devel Ther. 2021 Apr 7;15:1485-1493. doi: 10.2147/DDDT.S297642. eCollection 2021. — View Citation

Yao Y, Jiang J, Lin W, Yu Y, Guo Y, Zheng X. Efficacy of systemic lidocaine on postoperative quality of recovery and analgesia after video-assisted thoracic surgery: A randomized controlled trial. J Clin Anesth. 2021 Aug;71:110223. doi: 10.1016/j.jclinane.2021.110223. Epub 2021 Mar 3. — View Citation

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary pain score on numerical rating score static and dynamic score (defined as cough effort) on numerical rating score (values: 0-10 where the lower number means less pain and a better outcome) 1,3,6,12 hours after surgery (and on discharge from post- anaesthesia care unit [PACU]/after 24 hours- whichever comes sooner)
Primary cumulative opioid dose measured as fentanyl equivalent 12 hours after the end of the surgery (and on discharge from PACU/after 24 hours- whichever comes sooner)
Secondary incidence of severe hypotension (defined as a 20% drop of either mean arterial pressure (MAP), systolic blood pressure (SBP) or diastolic blood pressure (DBP) compared to baseline measured in the ward prior to surgery BP measured at 1,3,6,12 hour and on discharge from PACU or more frequently if needed
Secondary incidence of nausea and vomiting patients will be monitored for incidence of nausea and vomiting and incidence of those will be noted anytime during post-surgery period until discharge from PACU/after 24 hours- whichever comes sooner
Secondary incidence of priuritis patients will be monitored for incidence of priuritis and incidence of it will be noted anytime during post-surgery period until discharge from PACU/after 24 hours- whichever comes sooner
Secondary incidence of local anaesthetic systemic toxicity symptoms Patients will be monitored for the following symptoms: limbs numbness, tinnitus, seizures, coma, bradycardia (defined as heart rate below 45 beats per minute), severe ventrical arrhytmias. Incidence of those will be noted. anytime during post-surgery period until discharge from PACU/after 24 hours- whichever comes sooner
Secondary intra-operative cumulative opioid dose measured as fentanyl equivalent intra-operative
Secondary time to discharge from hospital measured as number of days in the hospital counting from the day of the surgery max. observation time: 30 days
See also
  Status Clinical Trial Phase
Completed NCT02952261 - Application of 3D Printing Technique in Small Pulmonary Nodule Localization N/A
Completed NCT05106283 - Comparison of Deep Serratus Anterior Plane Block and Combination of Deep and Superficial Serratus Anterior Plane Block N/A
Completed NCT05105282 - Comparison of Deep Serratus Anterior Plane Block and Superficial Serratus Anterior Plane Block N/A
Completed NCT05926817 - Effect of Virtual Reality on Patients With Acute Pain After Thoracoscopic Surgery N/A
Not yet recruiting NCT06061250 - Effect of Gum Chewing on Sore Throat After Double-lumen Tube Intubation N/A
Recruiting NCT04062045 - Efficacy of Continous Regional Anesthesia Using m. Erector Spinae Catheter After VATS Procedures N/A
Recruiting NCT03666299 - Lidocaine Infusion for Postthoracotomy Pain Syndrome N/A
Completed NCT03860480 - Erector Spinae Plane Block For Analgesia Following Video-Assisted Thoracoscopic Surgery N/A
Completed NCT03296449 - Comparison Between CPAP and HFJV During One-lung Ventilation in VATS N/A
Completed NCT06118593 - Why in Hospital After Wedge Resection
Completed NCT03648008 - Postoperative Analgesic Effect of Hydromorphone on Partial Pulmonary Resection Under Video-assisted Thoracoscopy Phase 4
Completed NCT05235815 - Ultrasound- Guided Retro Superior Costotransverse Ligament (SCTL) Compartment Block N/A
Completed NCT05121727 - Comparison of Erector Spinae Plane Block and Combination of Deep and Superficial Serratus Anterior Plane Block N/A
Recruiting NCT05907525 - Effect of Sevoflurane and Remimazolam on Arterial Oxygenation During One-lung Ventilation N/A
Recruiting NCT05834569 - Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients Phase 4
Completed NCT03916120 - Single Nucleotide Polymorphisms (SNPs) Associated With Postoperative Analgesic Failure
Recruiting NCT00425022 - VATS Lobectomy for Clinical Stage IB or II Lung Cancer Phase 2
Recruiting NCT05600569 - Registry of the Spanish Society of Thoracic Surgery
Completed NCT04511091 - Studio Osservazionale Retrospettivo Uneventful Vatslobectomy: Caratteristiche Cliniche All'Interno Del Registro Vats Group
Completed NCT04665531 - Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung Surgery N/A